EHC
Encompass Health Corp
-0.22 (-0.18%)123.69USD155K成交股數12.2B市值20.1本益比(近四季)2.0股價營收比+9.6%營收年增(近四季)2026-10-28下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 1.6B+10% | 1.6B+13% | 1.5B+9% | 1.5B+12% | 1.5B+11% | 1.4B+16% | 1.4B+14% | 1.3B+12% | 1.3B | 1.2B | 1.2B | 1.2B |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 62.6M | 58.2M | 56.1M | 59.4M | 52.3M | 54.5M | 54.0M | 50.5M | 50.2M | 49.8M | 55.4M | 43.4M |
| 營業利益 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | 154M+2% | 195M+61% | 127M+17% | 142M+25% | 152M+35% | 121M+42% | 108M+18% | 114M+30% | 113M | 85.3M | 91.4M | 87.7M |
| 淨利率 | 9.6% | 12.3% | 8.6% | 9.7% | 10.4% | 8.6% | 8.0% | 8.8% | 8.5% | 7.1% | 7.7% | 7.6% |
| 稀釋 EPS | 1.54+4% | 1.93+64% | 1.24+17% | 1.39+24% | 1.48+35% | 1.18+40% | 1.06+18% | 1.12+29% | 1.10 | 0.84 | 0.90 | 0.87 |
| 稀釋股數 | 100M | 101M | 102M | 102M | 102M | 102M | 102M | 102M | 102M | 101M | 101M | 101M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 108M | 111M | 48.7M | 99.1M | 95.8M | 85.4M | 148M | 154M | 134M | 99.7M | 118M | 85.0M |
| 應收帳款 | 687M | 676M | 611M | 613M | 623M | 593M | 576M | 590M | 619M | 536M | 532M | 515M |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 7.5B | 7.3B | 6.9B | 6.8B | 6.6B | 6.5B | 6.5B | 6.4B | 6.2B | 6.0B | 5.9B | 5.7B |
| 有息負債 | 2.6B | 2.5B | 2.4B | 2.3B | 2.3B | 2.4B | 2.3B | 2.7B | 2.7B | 2.7B | 2.7B | 2.7B |
| 總負債 | 4.0B | 3.9B | 3.7B | 3.7B | 3.7B | 3.7B | 3.7B | 3.9B | 3.8B | 3.8B | 3.8B | 3.8B |
| 股東權益 | 2.6B | 2.5B | 2.4B | 2.3B | 2.2B | 2.1B | 2.0B | 1.8B | 1.7B | 1.6B | 1.5B | 1.4B |
| 負債比 | 53.6% | 54.0% | 53.6% | 54.5% | 55.8% | 56.4% | 57.8% | 60.4% | 61.4% | 63.3% | 64.9% | 65.8% |
| 淨現金(現金 − 有息負債) | −2.5B | −2.4B | −2.3B | −2.2B | −2.2B | −2.3B | −2.2B | −2.5B | −2.5B | −2.6B | −2.6B | −2.6B |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 313M | – | – | 289M+21% | – | – | – | 239M | – | – | 228M |
| 資本支出 | – | 162M | – | – | 163M | – | – | – | 139M | – | – | 96.6M |
| 自由現金流 | – | 151M | – | – | 126M+26% | – | – | – | 99.4M | – | – | 131M |
| 折舊攤銷 | 90.4M | 87.3M | 82.4M | 79.9M | 79.2M | 78.0M | 78.4M | 72.9M | 70.3M | 67.3M | 72.6M | 63.9M |
| 買回庫藏股 | – | 71.6M | – | – | 32.1M | – | – | – | 0.00 | – | – | – |
| 現金股利 | – | 20.3M | – | – | 18.0M | – | – | – | 15.9M | – | – | 15.6M |
| 自由現金流率 | – | 9.5% | – | – | 8.6% | – | – | – | 7.6% | – | – | 11.3% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 5.9B
| Inpatient Rehabilitation | 5.9B | 100.0% | +10.5% |
|---|
產品／服務2025 年度 · 5.9B
| Inpatient | 5.8B | 97.0% | +10.1% |
|---|---|---|---|
| 其他 | 179M | 3.0% | +25.4% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 5.9B | +10.5% | 566M | 9.5% | 5.54 | 439M |
| FY2024 | 5.4B | +11.9% | 456M | 8.5% | 4.46 | 360M |
| FY2023 | 4.8B | +10.4% | 352M | 7.3% | 3.47 | 268M |
| FY2022 | 4.3B | +8.3% | 271M | 6.2% | 2.70 | 141M |
| FY2021 | 4.0B | +12.6% | 412M | 10.3% | 4.11 | 191M |
| FY2020 | 3.6B | -22.6% | 284M | 8.0% | 2.85 | 312M |
| FY2019 | 4.6B | +7.7% | 359M | 7.8% | 3.61 | 263M |
| FY2018 | 4.3B | – | 292M | 6.8% | 2.93 | 508M |